ImmediapressESMO Annual Meeting 2019: Menarini Ricerche Presents the Preclinical Characterization of MEN1611, a Novel PI3K Inhibitor in Development for the Treatment of Breast Cancer Di Redazione - 23 Settembre 2019 CondividiFacebook Twitter WhatsApp Linkedin Email Print Telegram